These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 15739256

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [Abstract] [Full Text] [Related]

  • 3. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    J Am Coll Cardiol; 2004 Aug 04; 44(3):720-32. PubMed ID: 15358046
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Low density lipoprotein cholesterol lowering: are the treatment guidelines still appropriate?
    Deslypere JP.
    Int J Clin Pract; 2000 Jun 04; 54(5):307-13. PubMed ID: 10954957
    [Abstract] [Full Text] [Related]

  • 6. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS, Mikhailidis DP.
    Curr Med Res Opin; 2006 Mar 04; 22(3):511-28. PubMed ID: 16574035
    [Abstract] [Full Text] [Related]

  • 7. Low density lipoprotein cholesterol: is lower better?
    Leiter LA.
    Can J Cardiol; 2000 Jan 04; 16 Suppl A():20A-2A. PubMed ID: 10653927
    [Abstract] [Full Text] [Related]

  • 8. [New results in the management of hypercholesterolemia].
    Sármán B.
    Orv Hetil; 2005 Sep 25; 146(39):1999-2004. PubMed ID: 16265867
    [Abstract] [Full Text] [Related]

  • 9. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Cheng AY, Leiter LA.
    Curr Opin Cardiol; 2006 Jul 25; 21(4):400-4. PubMed ID: 16755211
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
    McKenney JM.
    Am J Cardiol; 2005 Aug 22; 96(4A):60E-66E. PubMed ID: 16098846
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 22; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 12. Intensity of lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment among the elderly before and after the 2004 National Cholesterol Education Program Adult Treatment Panel III update.
    Nichols GA, Nag S, Chan W.
    Am Heart J; 2007 Sep 22; 154(3):554-60. PubMed ID: 17719305
    [Abstract] [Full Text] [Related]

  • 13. Rising to the challenge of the new NCEP ATP III guidelines: exceeding current therapeutic limitations.
    Brewer HB.
    Am J Manag Care; 2002 Feb 22; 8(2 Suppl):S23-8; discussion S45-7. PubMed ID: 11855698
    [Abstract] [Full Text] [Related]

  • 14. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 22; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 15. Lipid-lowering update 2001. Aggressive new goals.
    Fenske TK.
    Can Fam Physician; 2001 Feb 22; 47():303-9. PubMed ID: 11228031
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic lifestyle changes and drug treatment for high blood cholesterol in China and application of the Adult Treatment Panel III guidelines.
    Muntner P, Gu D, Reynolds RF, Wu X, Chen J, Whelton PK, He J.
    Am J Cardiol; 2005 Nov 01; 96(9):1260-5. PubMed ID: 16253594
    [Abstract] [Full Text] [Related]

  • 17. Future outlook: changing perspectives on best practice.
    Rader DJ.
    Am J Manag Care; 2002 Feb 01; 8(2 Suppl):S40-4; discussion S45-7. PubMed ID: 11855702
    [Abstract] [Full Text] [Related]

  • 18. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    Arterioscler Thromb Vasc Biol; 2004 Aug 01; 24(8):1329-30. PubMed ID: 15297284
    [No Abstract] [Full Text] [Related]

  • 19. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.
    Cullen MW, Stein JH, Gangnon R, McBride PE, Keevil JG.
    Am Heart J; 2008 Aug 01; 156(2):284-91. PubMed ID: 18657658
    [Abstract] [Full Text] [Related]

  • 20. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM, Kuller LH.
    Circulation; 2002 Jan 15; 105(2):136-9. PubMed ID: 11790688
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.